Hepacam Gene Megalencephalic Leukoencephalopathy with Subcortical Cysts 2A NGS Genetic DNA Test
Introduction to the Test
The Hepacam Gene Megalencephalic Leukoencephalopathy with Subcortical Cysts 2A NGS Genetic DNA Test is a specialized diagnostic tool used to identify genetic mutations associated with neurological disorders. This test employs Next-Generation Sequencing (NGS) technology to provide accurate and comprehensive results, making it essential for patients with symptoms of megalencephalic leukoencephalopathy.
What the Test Measures
This test specifically measures mutations in the Hepacam gene, which are linked to the development of megalencephalic leukoencephalopathy with subcortical cysts. By analyzing the genetic material extracted from blood or DNA samples, healthcare providers can gain insight into the underlying causes of neurological symptoms.
Who Should Consider This Test
Individuals exhibiting symptoms such as developmental delays, seizures, and abnormal brain imaging may be at risk for megalencephalic leukoencephalopathy. Additionally, a family history of neurological disorders may warrant consideration of this test. It is particularly beneficial for patients referred by neurologists or genetic specialists.
Benefits of Taking the Test
- Accurate identification of genetic mutations.
- Informed decision-making regarding treatment options.
- Enhanced understanding of the condition for patients and families.
- Potential for targeted therapies based on genetic findings.
Understanding Your Results
Results from the Hepacam Gene Megalencephalic Leukoencephalopathy with Subcortical Cysts 2A NGS Genetic DNA Test will be interpreted by qualified healthcare professionals. They will provide guidance on the implications of the findings and discuss potential next steps in management or treatment.
Test Pricing
Price Type | Price (KSh) |
---|---|
Discount Price | 40000 |
Regular Price | 56000 |
Sample Collection and Turnaround Time
The sample for this test can be collected through blood or extracted DNA, or even a drop of blood on an FTA card. The expected turnaround time for results is approximately 3 to 4 weeks.
Pre-Test Instructions
Before undergoing the Hepacam Gene Megalencephalic Leukoencephalopathy with Subcortical Cysts 2A NGS Genetic DNA Test, patients are advised to have a genetic counseling session to create a pedigree chart of family members affected by this condition.
Book Your Test Today!
We have branches across Kenya and offer convenient home sample collection services. Don’t wait to get the answers you need. Book the Hepacam Gene Megalencephalic Leukoencephalopathy with Subcortical Cysts 2A NGS Genetic DNA Test today! For more information, call or WhatsApp us at +254711564616.